Clinical Trials Logo

Filter by:
NCT ID: NCT01258621 Completed - Clinical trials for Pancreatic Lesions Located at Body or Tail.

Learning Curve for Laparoscopic Distal Pancreatectomy

Start date: March 2009
Phase: N/A
Study type: Interventional

Laparoscopic distal pancreatectomy (LDP) for benign and borderline pancreatic lesions has recently becoming the treatment of choice in experienced centres. No data have been published about learning curve so far. The purpose of this study was to identify the learning curve period for performing LDP.

NCT ID: NCT01257984 Completed - Contraception Clinical Trials

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The objective of the study is to evaluate the effect of the dispenser's buzzer function on compliance with daily tablet intake of an ethinyl estradiol (EE) + drospirenone (DRSP) containing oral contraceptive (OC) in a flexible extended regimen when administered for approximately 12 months to healthy female volunteers who request contraception.

NCT ID: NCT01257672 Completed - Vomiting Clinical Trials

Symptomatic Treatment of Acute Gastroenteritis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

Vomiting in children with acute gastroenteritis is a major factor of failure of oral rehydration therapy. Effective symptomatic treatment of vomiting would lead to an important reduction in the use of Intravenous Fluid Therapy. Available evidence on symptomatic treatment of vomiting shows the efficacy of the most recently registered molecule (ondansetron) but a proper evaluation of antiemetics drugs largely used in clinical practice, such as domperidone, is lacking. The aim of this multicentre, double-blind randomized controlled trial is to compare the efficacy of ondansetron and domperidone for the symptomatic treatment of vomiting in children with acute gastroenteritis who have failed Oral Rehydration Therapy.

NCT ID: NCT01257230 Completed - Asthma Clinical Trials

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The aim of the study is to evaluate efficacy and safety of a 48-week treatment with two doses of tiotropium bromide compared to placebo in adolescent patients with moderate persistent asthma. Efficacy and safety will be assessed by measuring lung function parameters and evaluating the effects on asthma exacerbations, on Quality of life, on health care resource utilisation an on the number of adverse events.

NCT ID: NCT01257204 Completed - Hepatitis C Virus Clinical Trials

Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

Start date: December 2010
Phase: Phase 2
Study type: Interventional

To identify a shorter duration of antiviral therapy (12 or 16 weeks) for the combination of daclatasvir with pegylated interferon alfa-2a and ribavirin.

NCT ID: NCT01256775 Completed - Clinical trials for Intermittent Claudication

Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Start date: September 2003
Phase: Phase 2
Study type: Interventional

Peripheral arterial disease (PAD) is almost invariably associated with a generalized atherosclerotic involvement of the arterial tree and endothelial dysfunction. Previous short term studies showed improvement of vascular reactivity and walking capacity in PAD patients by measures aimed at restoring Nitric Oxide (NO) production. NO is also known to prevent the progression of atherosclerosis. We wished to assess whether the prolonged administration of a NO-donating agent (NCX 4016) improves the functional capacity of PAD patients and affects the progression of atherosclerosis as assessed by carotid intima-media thickness (IMT). Four hundred forty two patients with stable intermittent claudication were enrolled in a prospective, double blind, placebo-controlled study and randomized to either NCX 4016 800mg bid or its placebo for 6 months. The primary study outcome was the absolute claudication distance (ACD) on a constant treadmill test (10% incline, 3km/hr); main secondary end-point was the change of the mean far-wall right common carotid artery IMT.

NCT ID: NCT01255969 Completed - Clinical trials for Patients on Dialysis (Hemodialysis, Peritoneal Dialysis)

EXerCise Introduction To Enhance Performance in Dialysis(EXCITE)

EXCITE
Start date: April 2010
Phase: Phase 4
Study type: Interventional

To evaluate if a model of intervention based on a low-grade physical program prescribed in the dialysis centre and performed at home can modify the functional capacity and quality of life, reduce the risk of cardiovascular and all-causes mortality, non-fatal cardiovascular events and vascular access failure in dialysis patients.

NCT ID: NCT01255722 Completed - Clinical trials for Coronary Artery Disease

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

X-ACT
Start date: November 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate the (statistical) non-inferiority of iobitridol (Xenetix® 350) when compared to contrast agents with higher iodine concentrations, iopromide (Ultravist® 370) and iomeprol (Iomeron® 400) in terms of coronary CT scan evaluability (quality and interpretability of images).

NCT ID: NCT01255449 Completed - Clinical trials for Hematopoietic Stem Cell Transplantation

Respiratory Impedance and Obliterative Bronchiolitis

FOT-BOS
Start date: December 2010
Phase: N/A
Study type: Interventional

The aim of the present study will be to test the hypothesis that changes in within-breath total respiratory input impedance (Zrs) may provide an early evidence of obliterative bronchiolitis after allogeneic hematopoietic stem cell transplantation (HSCT). Before and after HSCT, Zrs will be measured by a modified forced oscillation technique (FOT) during spontaneous breathing both at baseline and 30 min after albuterol inhalation . Such technique may be particularly sensitive to small changes in lung mechanics observed in the early stages of peripheral airflow obstruction.

NCT ID: NCT01255358 Completed - Genetic Syndrome Clinical Trials

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

IEDAT01
Start date: February 2011
Phase: Phase 2
Study type: Interventional

Multi-centre, single arm, open label, 6 months, phase II study to evaluate the effect of Ery-Dex in improving Central Nervous System (CNS) symptoms in patients with Ataxia Teleangiectasia (AT). The study consists of a screening period (max duration of 30 days) and a treatment period (duration 6 months).